glp-1 receptor agonist agonists and next-generation metabolic hormone therapies in chronic kidney disease π§π΅π² ππ³π³π²π°π πΌπ³ πππ£-π π₯π²π°π²π½ππΌπΏ
Description
Same duration, similar results
L.HabenerJ
Food supplements should not be used as a substitute for a varied and balanced diet
& Brady, M
And for Medicaid patients who need GLP-1 medications, Pennsylvania is one of 13 states nationwide that allows approval for the treatment of obesity
It increases the risk for multiple metabolic complications including type 2 diabetes (T2D), metabolic-dysfunction associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease), cardiovascular disease as well as many mechanical complications such as osteoarthritis and obstructive sleep apnoea (OSA) [3]
